Drugmakers are capping inhaler prices at $35

Drugmakers are capping inhaler prices at

A woman using an inhaler.  BSIP | Universal Images Group | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers will soon get a whole lot cheaper for some Americans.  Three of the world’s largest inhaler makers have agreed to cap the … Read more

Altimmune weight loss drug minimized muscle mass loss in trial

Altimmune weight loss drug minimized muscle mass loss in trial

Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding that could set it apart in a potentially crowded market. Altimmune is one of several smaller biotech companies that are pushing to compete directly with Novo Nordisk and Eli Lilly … Read more

Moderna moves three vaccines into final stage trials

Moderna moves three vaccines into final stage trials

Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said. The update brings Moderna a step closer to having multiple products … Read more

Novo Nordisk’s Ozempic can be made for less than $5 a month: study

Novo Nordisk’s Ozempic can be made for less than  a month: study

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  Lee Smith | Reuters The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection in the U.S. before insurance, a … Read more

FDA approves Merck drug sotatercept for rare, deadly lung condition

FDA approves Merck drug sotatercept for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with pulmonary arterial hypertension. The decision … Read more

Moderna says new Covid vaccine showed positive late-stage data

Moderna says new Covid vaccine showed positive late-stage data

A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot in a late-stage trial.  The results come as Moderna competes with rival Pfizer for more share … Read more

Viking Therapeutics weight loss pill shows positive study results

Viking Therapeutics weight loss pill shows positive study results

Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares jumped more than 10% in premarket trading Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker’s … Read more

Nvidia’s AI ambitions in medicine and health care are becoming clear

Nvidia’s AI ambitions in medicine and health care are becoming clear

Nvidia CEO Jensen Huang delivers a keynote address during the Nvidia GTC Conference at the SAP Center in San Jose, California, on March 18, 2024. Justin Sullivan | Getty Images Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health … Read more

Amgen aims to enter weight loss drug market with a new approach

Amgen aims to enter weight loss drug market with a new approach

The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable … Read more

How much people are willing to spend

How much people are willing to spend

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts.  But some patients are willing to pay more out of … Read more